Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | FBP1 | P09467 | 13/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1906746 | 0.84 | KMT2A (0.51) | NLRP3KMT2AFBP1ALDH1A1MAPT | |
| SCHEMBL7378828 | 0.82 | ADAMTS4 (0.59) | NLRP3KMT2AFBP1ALDH1A1MAPT | |
| Hydrochloric Acid SCHEMBL7456085 | 0.81 | ADAMTS4 (0.57) | NLRP3KMT2AFBP1ALDH1A1MAPT | |
| SCHEMBL171036 | 0.77 | KMT2A (0.61) | NLRP3KMT2AFBP1ALDH1A1MAPT | |
| SCHEMBL7379009 | 0.76 | KMT2A (0.49) | KMT2AFBP1 | |
| Hydrochloric Acid SCHEMBL7844930 | 0.75 | KMT2A (0.48) | KMT2AFBP1 | |
| Hydrochloric Acid SCHEMBL7704939 | 0.75 | KMT2A (0.48) | KMT2AFBP1 | |
| SCHEMBL7410148 | 0.74 | SLC1A3 (0.55) | KMT2AALDH1A1 | |
| SCHEMBL19040574 | 0.74 | KMT2A (0.50) | NLRP3KMT2AFBP1 | |
| SCHEMBL9888787 | 0.72 | FBP1 (0.63) | NLRP3KMT2AFBP1ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0922039-A1 | CYCLIC CARBAMATES AND ISOXAZOLIDINES AS IIB/IIIA ANTAGONISTS | Du Pont Pharmaceuticals Company (US) | 1999-06-16 | — | — | EP | disclosed |
| WO-1998006707-A1 | CYCLIC CARBAMATES AND ISOXAZOLIDINES AS IIB/IIIA ANTAGONISTS | DUPONT PHARMACEUTICALS COMPANY (US) | 1998-02-19 | — | — | WO | disclosed |